Cathie Wood: 32 Intellia Therapeutics transactions (ARK Invest / NTLA)

32 Cathie Wood Intellia Therapeutics Trades

Cathie Wood acquired 13 Million Intellia Therapeutics shares worth $108 Million. That's 1.10% of their equity portfolio (28th largest holding). The investor owns 11.77% of the outstanding Intellia Therapeutics stock. The first Intellia Therapeutics trade was made in Q4 2016. Since then Cathie Wood bought shares 24 more times and sold shares on seven occasions. The investor's estimated purchase price is $430 Million, resulting in a loss of 75%.

Avg closing price

Price range

Increased shares by 3.8% (+475 Thousand shares) Q1 2025

Avg closing price $10.13

Price range $7.11 - $12.80

Increased shares by 2.3% (+281 Thousand shares) Q4 2024

Avg closing price $15.50

Price range $11.41 - $21.08

Increased shares by 5.7% (+660 Thousand shares) Q3 2024

Avg closing price $23.05

Price range $19.72 - $27.36

Increased shares by 5.5% (+607 Thousand shares) Q2 2024

Avg closing price $23.81

Price range $20.02 - $27.22

Sold 3.7% shares (-423 Thousand shares) Q1 2024

Avg closing price $27.78

Price range $23.82 - $32.80

Increased shares by 14.7% (+1.46 Million shares) Q4 2023

Avg closing price $28.74

Price range $23.16 - $32.34

Increased shares by 4.4% (+423 Thousand shares) Q3 2023

Avg closing price $38.80

Price range $31.62 - $45.78

Sold 3.2% shares (-311 Thousand shares) Q2 2023

Avg closing price $40.55

Price range $34.58 - $46.03

Increased shares by 4.4% (+416 Thousand shares) Q1 2023

Avg closing price $39.22

Price range $33.30 - $44.82

Sold 2.4% shares (-236 Thousand shares) Q4 2022

Avg closing price $47.55

Price range $33.21 - $62.69

Increased shares by 1.5% (+142 Thousand shares) Q3 2022

Avg closing price $62.04

Price range $53.92 - $71.70

Increased shares by 5.9% (+534 Thousand shares) Q2 2022

Avg closing price $50.78

Price range $38.49 - $76.21

Increased shares by 13.4% (+1.06 Million shares) Q1 2022

Avg closing price $84.72

Price range $58.27 - $118.99

Increased shares by 17.4% (+1.17 Million shares) Q4 2021

Avg closing price $125.27

Price range $100.76 - $138.36

Sold 12.2% shares (-941 Thousand shares) Q3 2021

Avg closing price $151.40

Price range $132.37 - $176.78

Sold 20.1% shares (-1.93 Million shares) Q2 2021

Avg closing price $77.87

Price range $60.88 - $161.91

Sold 14.1% shares (-1.58 Million shares) Q1 2021

Avg closing price $67.12

Price range $46.59 - $83.68

Sold 1.9% shares (-213 Thousand shares) Q4 2020

Avg closing price $36.31

Price range $18.83 - $63.53

Increased shares by 0.0% (+1.37 Thousand shares) Q3 2020

Avg closing price $20.85

Price range $17.47 - $24.93

Increased shares by 11.4% (+1.16 Million shares) Q2 2020

Avg closing price $16.99

Price range $11.14 - $22.87

News about Intellia Therapeutics Inc and Cathie Wood

Cathie Wood''s ARK buys Intellia stock, sells Tesla and Verve

https://www.investing.com/news/company-news/cathie-woods-ark-buys-intellia-stock-sells-tesla-and-verve-93CH-3509465

Investing.com, 10 months ago

3 Stocks Cathie Wood Just Bought to Get Back on Track in the Second Half of 2024

Wood added to her positions in Palantir, Archer Aviation, and Intellia Therapeutics on Monday. Palantir is one of her largest holdings, and the big data anal...

fool.com, 10 months ago

Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for June 2024

Investors looking for long-term returns should consider investing in strong buy Cathie Wood stocks this month. The ARK Invest Chief Executive Officer (CEO) g...

investorplace.com, 11 months ago